

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.42530657 |
| 2 | microglial cell activation (GO:0001774) | 4.86573974 |
| 3 | oligosaccharide catabolic process (GO:0009313) | 4.48270424 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.41320519 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.41320519 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.41320519 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.41320519 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.41320519 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.41320519 |
| 10 | response to muramyl dipeptide (GO:0032495) | 4.36701344 |
| 11 | regulation of chemokine secretion (GO:0090196) | 4.35589176 |
| 12 | regulation of vitamin metabolic process (GO:0030656) | 4.25592186 |
| 13 | hemidesmosome assembly (GO:0031581) | 4.19825390 |
| 14 | regulation of chronic inflammatory response (GO:0002676) | 4.07360766 |
| 15 | interferon-gamma secretion (GO:0072643) | 4.04303121 |
| 16 | glycosphingolipid catabolic process (GO:0046479) | 3.98980705 |
| 17 | macrophage activation (GO:0042116) | 3.85593068 |
| 18 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.76359319 |
| 19 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.75399602 |
| 20 | glycolipid catabolic process (GO:0019377) | 3.73252806 |
| 21 | desmosome organization (GO:0002934) | 3.72849516 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 3.71211693 |
| 23 | regulation of chemokine biosynthetic process (GO:0045073) | 3.69527089 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.69181485 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.63970301 |
| 26 | positive regulation of chemokine secretion (GO:0090197) | 3.63288156 |
| 27 | T-helper 1 type immune response (GO:0042088) | 3.60025472 |
| 28 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.49490206 |
| 29 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.47973668 |
| 30 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.41181871 |
| 31 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.37910073 |
| 32 | positive regulation of p38MAPK cascade (GO:1900745) | 3.37653690 |
| 33 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.37210009 |
| 34 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.32530736 |
| 35 | positive regulation of type 2 immune response (GO:0002830) | 3.27998437 |
| 36 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.27619340 |
| 37 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.27292152 |
| 38 | response to peptidoglycan (GO:0032494) | 3.25444502 |
| 39 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.25157625 |
| 40 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.24989809 |
| 41 | ceramide catabolic process (GO:0046514) | 3.23024158 |
| 42 | myeloid dendritic cell differentiation (GO:0043011) | 3.21916062 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.13806729 |
| 44 | monocyte chemotaxis (GO:0002548) | 3.13606848 |
| 45 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.12281117 |
| 46 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.11437186 |
| 47 | germinal center formation (GO:0002467) | 3.10685293 |
| 48 | positive regulation of interferon-alpha production (GO:0032727) | 3.06103095 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.06031420 |
| 50 | regulation of cholesterol storage (GO:0010885) | 3.05681257 |
| 51 | wound healing, spreading of epidermal cells (GO:0035313) | 3.02457138 |
| 52 | positive regulation of antigen processing and presentation (GO:0002579) | 3.00734232 |
| 53 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.98504351 |
| 54 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.98504351 |
| 55 | decidualization (GO:0046697) | 2.97617368 |
| 56 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.96265438 |
| 57 | negative regulation of fatty acid transport (GO:2000192) | 2.93301504 |
| 58 | cellular response to lipopolysaccharide (GO:0071222) | 2.92019625 |
| 59 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.91490514 |
| 60 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.90240113 |
| 61 | regulation of interferon-alpha production (GO:0032647) | 2.90140593 |
| 62 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.88831355 |
| 63 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.88831355 |
| 64 | response to protozoan (GO:0001562) | 2.86806496 |
| 65 | negative regulation of lipid storage (GO:0010888) | 2.86793143 |
| 66 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85753712 |
| 67 | response to host immune response (GO:0052572) | 2.85753712 |
| 68 | response to thyroid hormone (GO:0097066) | 2.85527087 |
| 69 | positive regulation of extracellular matrix organization (GO:1903055) | 2.83492366 |
| 70 | wound healing, spreading of cells (GO:0044319) | 2.82166355 |
| 71 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.81235465 |
| 72 | cellular response to molecule of bacterial origin (GO:0071219) | 2.80407065 |
| 73 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.80405410 |
| 74 | cellular response to arsenic-containing substance (GO:0071243) | 2.79950995 |
| 75 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78542138 |
| 76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.77183730 |
| 77 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.77063981 |
| 78 | granulocyte activation (GO:0036230) | 2.76278051 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.75453405 |
| 80 | membrane lipid catabolic process (GO:0046466) | 2.75143995 |
| 81 | positive regulation of cholesterol efflux (GO:0010875) | 2.74769277 |
| 82 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.72640853 |
| 83 | neutrophil activation (GO:0042119) | 2.70461075 |
| 84 | superoxide anion generation (GO:0042554) | 2.70324278 |
| 85 | adhesion of symbiont to host cell (GO:0044650) | 2.69343981 |
| 86 | virion attachment to host cell (GO:0019062) | 2.69343981 |
| 87 | endothelial cell chemotaxis (GO:0035767) | 2.68516577 |
| 88 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67492014 |
| 89 | mitotic cell cycle arrest (GO:0071850) | 2.67357480 |
| 90 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.67077817 |
| 91 | response to host (GO:0075136) | 2.67077817 |
| 92 | response to host defenses (GO:0052200) | 2.67077817 |
| 93 | response to progesterone (GO:0032570) | 2.66814276 |
| 94 | low-density lipoprotein particle clearance (GO:0034383) | 2.66319457 |
| 95 | osteoclast differentiation (GO:0030316) | 2.65865569 |
| 96 | activation of MAPKKK activity (GO:0000185) | 2.65250596 |
| 97 | ovulation from ovarian follicle (GO:0001542) | 2.64646708 |
| 98 | positive regulation of mRNA catabolic process (GO:0061014) | 2.62272537 |
| 99 | positive regulation of heat generation (GO:0031652) | 2.62071085 |
| 100 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.61323059 |
| 101 | regulation of monocyte differentiation (GO:0045655) | 2.60521302 |
| 102 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.58306780 |
| 103 | type I interferon signaling pathway (GO:0060337) | 2.57112674 |
| 104 | cellular response to type I interferon (GO:0071357) | 2.57112674 |
| 105 | ovulation (GO:0030728) | 2.56979529 |
| 106 | positive regulation of interleukin-6 production (GO:0032755) | 2.56671505 |
| 107 | immunoglobulin mediated immune response (GO:0016064) | 2.56358607 |
| 108 | regulation of interleukin-6 production (GO:0032675) | 2.55876179 |
| 109 | response to type I interferon (GO:0034340) | 2.55779045 |
| 110 | sphingolipid catabolic process (GO:0030149) | 2.55003322 |
| 111 | cellular response to biotic stimulus (GO:0071216) | 2.54050018 |
| 112 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.53553707 |
| 113 | myeloid dendritic cell activation (GO:0001773) | 2.52122382 |
| 114 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.52059541 |
| 115 | eosinophil chemotaxis (GO:0048245) | 2.52000169 |
| 116 | defense response to protozoan (GO:0042832) | 2.51503668 |
| 117 | cytokine secretion (GO:0050663) | 2.51043011 |
| 118 | regulation of immunoglobulin secretion (GO:0051023) | 2.50835893 |
| 119 | regulation of type 2 immune response (GO:0002828) | 2.50770413 |
| 120 | regulation of antigen processing and presentation (GO:0002577) | 2.50017069 |
| 121 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.49931802 |
| 122 | regulation of phospholipase A2 activity (GO:0032429) | 2.49822842 |
| 123 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.49123032 |
| 124 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.48491626 |
| 125 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.48132191 |
| 126 | positive regulation of osteoclast differentiation (GO:0045672) | 2.47507478 |
| 127 | regulation of fever generation (GO:0031620) | 2.46971320 |
| 128 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.46758676 |
| 129 | dendritic cell differentiation (GO:0097028) | 2.46322787 |
| 130 | amino sugar catabolic process (GO:0046348) | 2.46055082 |
| 131 | regulation of heat generation (GO:0031650) | 2.44978463 |
| 132 | positive regulation of astrocyte differentiation (GO:0048711) | 2.44691905 |
| 133 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.44130461 |
| 134 | positive regulation of lipid storage (GO:0010884) | 2.43883309 |
| 135 | atrioventricular valve morphogenesis (GO:0003181) | 2.43772556 |
| 136 | regulation of interleukin-12 production (GO:0032655) | 2.43648323 |
| 137 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.43186413 |
| 138 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.41439007 |
| 139 | regulation of p38MAPK cascade (GO:1900744) | 2.40876731 |
| 140 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.40643472 |
| 141 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.40643472 |
| 142 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.39872808 |
| 143 | myeloid cell activation involved in immune response (GO:0002275) | 2.39212336 |
| 144 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.37534966 |
| 145 | keratinocyte proliferation (GO:0043616) | 2.37314916 |
| 146 | positive regulation of interferon-beta production (GO:0032728) | 2.37247603 |
| 147 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.36859524 |
| 148 | regulation of mononuclear cell migration (GO:0071675) | 2.35583080 |
| 149 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.34595193 |
| 150 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.34354419 |
| 151 | positive regulation of interleukin-12 production (GO:0032735) | 2.33968932 |
| 152 | myeloid leukocyte activation (GO:0002274) | 2.33361106 |
| 153 | positive regulation of sterol transport (GO:0032373) | 2.33019659 |
| 154 | positive regulation of cholesterol transport (GO:0032376) | 2.33019659 |
| 155 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.32790549 |
| 156 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.30782888 |
| 157 | cellular response to antibiotic (GO:0071236) | 2.30333335 |
| 158 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.30073083 |
| 159 | regulation of podosome assembly (GO:0071801) | 2.28559664 |
| 160 | negative regulation of protein autophosphorylation (GO:0031953) | 2.28038561 |
| 161 | positive regulation of chemokine production (GO:0032722) | 2.27800846 |
| 162 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.27766946 |
| 163 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.27572400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.56582646 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.06362411 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.47934614 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.81868720 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.51155349 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.26132652 |
| 7 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.67618986 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.67143505 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.65992449 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.64569080 |
| 11 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.56162849 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56077498 |
| 13 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.49383654 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.47336571 |
| 15 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36459090 |
| 16 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34967597 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.21701970 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11514880 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01135985 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.79998171 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79638620 |
| 22 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.79089418 |
| 23 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.79089418 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78649065 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78117999 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77938561 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.73622909 |
| 28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.73516486 |
| 29 | CJUN_26792858_Chip-Seq_BT549_Human | 1.71696597 |
| 30 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.71242943 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.70139982 |
| 32 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.69863490 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.68430286 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64509681 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60854563 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60433584 |
| 37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.57189519 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55055517 |
| 39 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.52684113 |
| 40 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.52684113 |
| 41 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.52684113 |
| 42 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.50578030 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.48520092 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.44878638 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43057199 |
| 46 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.42116799 |
| 47 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40649019 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33252171 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32491933 |
| 50 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31705287 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.29696726 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28829384 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.28414500 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26672021 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26436434 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25950549 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24668292 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23727462 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23727462 |
| 60 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23196780 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21844660 |
| 62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21520755 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21160166 |
| 64 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20191106 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19957750 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17992299 |
| 67 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17125296 |
| 68 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16834010 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10144409 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10076182 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09882508 |
| 72 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.09260296 |
| 73 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08307672 |
| 74 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07606816 |
| 75 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07241844 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06952516 |
| 77 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.06523957 |
| 78 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.05510088 |
| 79 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.05388302 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04576500 |
| 81 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04018205 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02733250 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01615705 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01034298 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00763040 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00666683 |
| 87 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99550034 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99527570 |
| 89 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98323175 |
| 90 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97188415 |
| 91 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96477351 |
| 92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96324866 |
| 93 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.96261984 |
| 94 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93939056 |
| 95 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.93544844 |
| 96 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93161111 |
| 97 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.93161032 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90561299 |
| 99 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89498648 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89189683 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87724551 |
| 102 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86945656 |
| 103 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86864971 |
| 104 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86655843 |
| 105 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86201321 |
| 106 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85876765 |
| 107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84841776 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84488810 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84093677 |
| 110 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83099728 |
| 111 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83009518 |
| 112 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81850150 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81511454 |
| 114 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79131621 |
| 115 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78812038 |
| 116 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78567832 |
| 117 | MYB_26560356_Chip-Seq_TH2_Human | 0.78114921 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75430583 |
| 119 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.75171007 |
| 120 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75138767 |
| 121 | * MAF_26560356_Chip-Seq_TH1_Human | 0.74582453 |
| 122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.73919305 |
| 123 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.72293852 |
| 124 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72173215 |
| 125 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.72027254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.89847878 |
| 2 | MP0003724_increased_susceptibility_to | 3.63163886 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.49340641 |
| 4 | MP0003941_abnormal_skin_development | 3.02647043 |
| 5 | MP0003828_pulmonary_edema | 2.79927862 |
| 6 | MP0003436_decreased_susceptibility_to | 2.75604256 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.55858963 |
| 8 | MP0003303_peritoneal_inflammation | 2.47130141 |
| 9 | MP0003453_abnormal_keratinocyte_physiol | 2.38229555 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.35328219 |
| 11 | MP0001851_eye_inflammation | 2.35061815 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.29559059 |
| 13 | MP0004947_skin_inflammation | 2.25188538 |
| 14 | MP0002419_abnormal_innate_immunity | 2.10766990 |
| 15 | MP0009278_abnormal_bone_marrow | 2.08324019 |
| 16 | MP0004381_abnormal_hair_follicle | 2.07354743 |
| 17 | MP0000383_abnormal_hair_follicle | 2.04794742 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.03918988 |
| 19 | MP0006082_CNS_inflammation | 2.03176860 |
| 20 | MP0009785_altered_susceptibility_to | 2.03015973 |
| 21 | MP0000604_amyloidosis | 2.00110642 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.97883223 |
| 23 | MP0001346_abnormal_lacrimal_gland | 1.95348326 |
| 24 | MP0003195_calcinosis | 1.93387653 |
| 25 | MP0002009_preneoplasia | 1.92644960 |
| 26 | MP0002060_abnormal_skin_morphology | 1.92516103 |
| 27 | MP0001853_heart_inflammation | 1.91242910 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.89312249 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.84814713 |
| 30 | MP0002796_impaired_skin_barrier | 1.84764415 |
| 31 | MP0001790_abnormal_immune_system | 1.84125352 |
| 32 | MP0005387_immune_system_phenotype | 1.84125352 |
| 33 | MP0009379_abnormal_foot_pigmentation | 1.77284717 |
| 34 | MP0005451_abnormal_body_composition | 1.72804133 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.67262541 |
| 36 | MP0004510_myositis | 1.61379435 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.58123679 |
| 38 | MP0001216_abnormal_epidermal_layer | 1.57961190 |
| 39 | MP0005025_abnormal_response_to | 1.57765306 |
| 40 | MP0002098_abnormal_vibrissa_morphology | 1.57159077 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.56947118 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.56801591 |
| 43 | * MP0002723_abnormal_immune_serum | 1.52937300 |
| 44 | MP0010678_abnormal_skin_adnexa | 1.52060988 |
| 45 | MP0004883_abnormal_blood_vessel | 1.48656684 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.46134879 |
| 47 | * MP0001800_abnormal_humoral_immune | 1.45390345 |
| 48 | * MP0002405_respiratory_system_inflammati | 1.44276495 |
| 49 | MP0005164_abnormal_response_to | 1.43854406 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.43261363 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.42766764 |
| 52 | MP0003075_altered_response_to | 1.40946811 |
| 53 | MP0000685_abnormal_immune_system | 1.38872153 |
| 54 | MP0003448_altered_tumor_morphology | 1.38344956 |
| 55 | MP0002332_abnormal_exercise_endurance | 1.37856940 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.37348110 |
| 57 | MP0005671_abnormal_response_to | 1.36857697 |
| 58 | MP0005023_abnormal_wound_healing | 1.36122490 |
| 59 | MP0003091_abnormal_cell_migration | 1.35146826 |
| 60 | MP0001501_abnormal_sleep_pattern | 1.32833111 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.31833334 |
| 62 | MP0002006_tumorigenesis | 1.31747524 |
| 63 | MP0005310_abnormal_salivary_gland | 1.31430882 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.29030738 |
| 65 | MP0003329_amyloid_beta_deposits | 1.25464564 |
| 66 | MP0001819_abnormal_immune_cell | 1.25365922 |
| 67 | MP0009764_decreased_sensitivity_to | 1.25083295 |
| 68 | MP0000343_altered_response_to | 1.24570481 |
| 69 | * MP0002420_abnormal_adaptive_immunity | 1.22569866 |
| 70 | MP0005390_skeleton_phenotype | 1.21862380 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.21714988 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.21714988 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.20614488 |
| 74 | MP0003690_abnormal_glial_cell | 1.19536550 |
| 75 | MP0000467_abnormal_esophagus_morphology | 1.16432209 |
| 76 | MP0002166_altered_tumor_susceptibility | 1.14748153 |
| 77 | MP0005166_decreased_susceptibility_to | 1.13769231 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.13233451 |
| 79 | MP0005464_abnormal_platelet_physiology | 1.11168412 |
| 80 | MP0008789_abnormal_olfactory_epithelium | 1.08951214 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 1.07884105 |
| 82 | MP0005058_abnormal_lysosome_morphology | 1.03420874 |
| 83 | MP0004043_abnormal_pH_regulation | 1.03275239 |
| 84 | MP0001542_abnormal_bone_strength | 1.00738694 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 1.00485391 |
| 86 | MP0001191_abnormal_skin_condition | 1.00102850 |
| 87 | MP0002090_abnormal_vision | 0.98115284 |
| 88 | MP0000858_altered_metastatic_potential | 0.97696833 |
| 89 | MP0010771_integument_phenotype | 0.96461951 |
| 90 | MP0000762_abnormal_tongue_morphology | 0.95340339 |
| 91 | MP0005647_abnormal_sex_gland | 0.94196585 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.93072592 |
| 93 | MP0000566_synostosis | 0.92682066 |
| 94 | MP0000372_irregular_coat_pigmentation | 0.91605432 |
| 95 | MP0008004_abnormal_stomach_pH | 0.90312217 |
| 96 | MP0008469_abnormal_protein_level | 0.88055409 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 0.87349558 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.87028653 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.86132236 |
| 100 | MP0005257_abnormal_intraocular_pressure | 0.85090206 |
| 101 | MP0005394_taste/olfaction_phenotype | 0.84127885 |
| 102 | MP0005499_abnormal_olfactory_system | 0.84127885 |
| 103 | MP0002933_joint_inflammation | 0.84038355 |
| 104 | MP0001873_stomach_inflammation | 0.83842962 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.82435475 |
| 106 | MP0009840_abnormal_foam_cell | 0.82218105 |
| 107 | MP0010368_abnormal_lymphatic_system | 0.82043818 |
| 108 | MP0005388_respiratory_system_phenotype | 0.82004426 |
| 109 | MP0002133_abnormal_respiratory_system | 0.82004426 |
| 110 | MP0000647_abnormal_sebaceous_gland | 0.81601622 |
| 111 | MP0000377_abnormal_hair_follicle | 0.81122264 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.80280090 |
| 113 | MP0009763_increased_sensitivity_to | 0.79698116 |
| 114 | MP0005165_increased_susceptibility_to | 0.79287195 |
| 115 | MP0006054_spinal_hemorrhage | 0.79016467 |
| 116 | MP0005501_abnormal_skin_physiology | 0.78554667 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.78522815 |
| 118 | MP0005365_abnormal_bile_salt | 0.78494112 |
| 119 | MP0002132_abnormal_respiratory_system | 0.78425146 |
| 120 | MP0000716_abnormal_immune_system | 0.78138463 |
| 121 | MP0010307_abnormal_tumor_latency | 0.77570084 |
| 122 | MP0000249_abnormal_blood_vessel | 0.77502816 |
| 123 | MP0001727_abnormal_embryo_implantation | 0.76665391 |
| 124 | MP0005275_abnormal_skin_tensile | 0.76388625 |
| 125 | MP0003795_abnormal_bone_structure | 0.74223947 |
| 126 | MP0003879_abnormal_hair_cell | 0.73428861 |
| 127 | MP0000920_abnormal_myelination | 0.73422385 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.69573275 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.66839492 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.61433130 |
| 131 | MP0003634_abnormal_glial_cell | 0.60044721 |
| 132 | MP0003806_abnormal_nucleotide_metabolis | 0.59141663 |
| 133 | MP0003045_fibrosis | 0.58760288 |
| 134 | MP0003221_abnormal_cardiomyocyte_apopto | 0.58125523 |
| 135 | MP0008874_decreased_physiological_sensi | 0.57093353 |
| 136 | MP0002429_abnormal_blood_cell | 0.55595547 |
| 137 | MP0003646_muscle_fatigue | 0.55347787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.04673598 |
| 2 | Stomach cancer (HP:0012126) | 4.84857836 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 4.78574957 |
| 4 | Prostate neoplasm (HP:0100787) | 4.58142099 |
| 5 | Loss of speech (HP:0002371) | 4.39265859 |
| 6 | Nuclear cataract (HP:0100018) | 4.18466790 |
| 7 | Thick nail (HP:0001805) | 4.11294027 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.07405243 |
| 9 | Neurofibrillary tangles (HP:0002185) | 4.06222447 |
| 10 | Disinhibition (HP:0000734) | 4.01348284 |
| 11 | Milia (HP:0001056) | 3.79694523 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.74995195 |
| 13 | Lip pit (HP:0100267) | 3.63734206 |
| 14 | Plantar hyperkeratosis (HP:0007556) | 3.45906060 |
| 15 | Glomerulonephritis (HP:0000099) | 3.38572836 |
| 16 | Anhidrosis (HP:0000970) | 3.34368417 |
| 17 | Orchitis (HP:0100796) | 3.31797253 |
| 18 | Onycholysis (HP:0001806) | 3.25462145 |
| 19 | Distal lower limb muscle weakness (HP:0009053) | 3.15032495 |
| 20 | Axonal loss (HP:0003447) | 3.10666184 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 3.08852832 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.04626275 |
| 23 | Myositis (HP:0100614) | 3.02674465 |
| 24 | Fragile nails (HP:0001808) | 3.00627869 |
| 25 | Pustule (HP:0200039) | 2.95801470 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 2.90159191 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.88700803 |
| 28 | Urethral obstruction (HP:0000796) | 2.86295513 |
| 29 | Ulnar claw (HP:0001178) | 2.84893206 |
| 30 | Mutism (HP:0002300) | 2.83130171 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 2.80035558 |
| 32 | Optic neuritis (HP:0100653) | 2.80035558 |
| 33 | Alopecia of scalp (HP:0002293) | 2.77411044 |
| 34 | Myocardial infarction (HP:0001658) | 2.77326162 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76878342 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 2.75735307 |
| 37 | Tetraparesis (HP:0002273) | 2.74639112 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.72888700 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.72595118 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68502351 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68502351 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68502351 |
| 43 | Apathy (HP:0000741) | 2.67295183 |
| 44 | Malnutrition (HP:0004395) | 2.65792435 |
| 45 | Palmoplantar hyperkeratosis (HP:0000972) | 2.63994611 |
| 46 | Atrophic scars (HP:0001075) | 2.63764681 |
| 47 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.63693206 |
| 48 | Parakeratosis (HP:0001036) | 2.61109584 |
| 49 | Hematochezia (HP:0002573) | 2.58049373 |
| 50 | Premature loss of primary teeth (HP:0006323) | 2.56527918 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.54849545 |
| 52 | Diminished motivation (HP:0000745) | 2.52626441 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 2.51069941 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.51069941 |
| 55 | Increased serum ferritin (HP:0003281) | 2.50954963 |
| 56 | Palmar hyperkeratosis (HP:0010765) | 2.48627192 |
| 57 | Neuronal loss in central nervous system (HP:0002529) | 2.46643814 |
| 58 | Alveolar cell carcinoma (HP:0006519) | 2.46218957 |
| 59 | Nephritis (HP:0000123) | 2.46060054 |
| 60 | Nausea (HP:0002018) | 2.45492974 |
| 61 | Amyloidosis (HP:0011034) | 2.44434846 |
| 62 | Metaphyseal irregularity (HP:0003025) | 2.41205013 |
| 63 | Gingivitis (HP:0000230) | 2.39982422 |
| 64 | Absent eyebrow (HP:0002223) | 2.37894144 |
| 65 | Right ventricular cardiomyopathy (HP:0011663) | 2.37173501 |
| 66 | Abnormality of the nasal septum (HP:0000419) | 2.34565612 |
| 67 | Abnormal hemoglobin (HP:0011902) | 2.33682200 |
| 68 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.32314533 |
| 69 | Hypotrichosis (HP:0001006) | 2.31180507 |
| 70 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.29203048 |
| 71 | Periodontitis (HP:0000704) | 2.28859521 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.25809938 |
| 73 | Cheilitis (HP:0100825) | 2.24835615 |
| 74 | Persistence of primary teeth (HP:0006335) | 2.24632786 |
| 75 | Popliteal pterygium (HP:0009756) | 2.21439148 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 2.21253375 |
| 77 | Increased CSF protein (HP:0002922) | 2.20847771 |
| 78 | Recurrent skin infections (HP:0001581) | 2.17906959 |
| 79 | Recurrent fungal infections (HP:0002841) | 2.16102409 |
| 80 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15081987 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.13796435 |
| 82 | Oligodontia (HP:0000677) | 2.10086591 |
| 83 | Prolonged neonatal jaundice (HP:0006579) | 2.10051682 |
| 84 | Conical tooth (HP:0000698) | 2.09611263 |
| 85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.09533698 |
| 86 | Hyperparathyroidism (HP:0000843) | 2.08542374 |
| 87 | Vasculitis (HP:0002633) | 2.07376696 |
| 88 | Gangrene (HP:0100758) | 2.06893356 |
| 89 | Abnormality of complement system (HP:0005339) | 2.05977994 |
| 90 | Steatorrhea (HP:0002570) | 2.05971164 |
| 91 | Natal tooth (HP:0000695) | 2.04968579 |
| 92 | Purpura (HP:0000979) | 2.04185102 |
| 93 | Nail dystrophy (HP:0008404) | 2.00272741 |
| 94 | Pulmonary infiltrates (HP:0002113) | 2.00135589 |
| 95 | Exocrine pancreatic insufficiency (HP:0001738) | 1.99986644 |
| 96 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.99220652 |
| 97 | Osteomyelitis (HP:0002754) | 1.98384219 |
| 98 | Xerostomia (HP:0000217) | 1.98171565 |
| 99 | Stenosis of the external auditory canal (HP:0000402) | 1.97351381 |
| 100 | Xanthomatosis (HP:0000991) | 1.97333652 |
| 101 | Stomatitis (HP:0010280) | 1.97043489 |
| 102 | Inappropriate behavior (HP:0000719) | 1.95737756 |
| 103 | Keratoconjunctivitis (HP:0001096) | 1.95574887 |
| 104 | Colitis (HP:0002583) | 1.94845256 |
| 105 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.94360113 |
| 106 | Complement deficiency (HP:0004431) | 1.94337253 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94296257 |
| 108 | Mucopolysacchariduria (HP:0008155) | 1.94296257 |
| 109 | Bone pain (HP:0002653) | 1.94171679 |
| 110 | Submucous cleft hard palate (HP:0000176) | 1.94007107 |
| 111 | Progressive neurologic deterioration (HP:0002344) | 1.93753271 |
| 112 | Aplasia involving bones of the extremities (HP:0009825) | 1.93739100 |
| 113 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.93739100 |
| 114 | Aplasia of the phalanges of the hand (HP:0009802) | 1.93739100 |
| 115 | Abnormality of the periventricular white matter (HP:0002518) | 1.93350520 |
| 116 | Obstructive lung disease (HP:0006536) | 1.93216196 |
| 117 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93216196 |
| 118 | Increased IgE level (HP:0003212) | 1.92220383 |
| 119 | Upper limb muscle weakness (HP:0003484) | 1.92072208 |
| 120 | Peripheral demyelination (HP:0011096) | 1.90970578 |
| 121 | Hypoplasia of dental enamel (HP:0006297) | 1.90122172 |
| 122 | Bifid scrotum (HP:0000048) | 1.89576239 |
| 123 | Cellulitis (HP:0100658) | 1.89566727 |
| 124 | Arterial tortuosity (HP:0005116) | 1.89015410 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.88429206 |
| 126 | Basal ganglia calcification (HP:0002135) | 1.87717257 |
| 127 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86769422 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.85068285 |
| 129 | Cardiomegaly (HP:0001640) | 1.84980424 |
| 130 | Dementia (HP:0000726) | 1.81673802 |
| 131 | Abnormality of the prostate (HP:0008775) | 1.81012909 |
| 132 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80781633 |
| 133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80781633 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80781633 |
| 135 | Arterial thrombosis (HP:0004420) | 1.80159364 |
| 136 | Asymmetry of the thorax (HP:0001555) | 1.79835045 |
| 137 | Autoimmune thrombocytopenia (HP:0001973) | 1.79316258 |
| 138 | Autoimmune hemolytic anemia (HP:0001890) | 1.78510741 |
| 139 | Protuberant abdomen (HP:0001538) | 1.76020873 |
| 140 | Polyneuropathy (HP:0001271) | 1.75031395 |
| 141 | Thin bony cortex (HP:0002753) | 1.74027759 |
| 142 | Recurrent viral infections (HP:0004429) | 1.72108724 |
| 143 | Tubulointerstitial fibrosis (HP:0005576) | 1.68425887 |
| 144 | Thoracic kyphosis (HP:0002942) | 1.67378822 |
| 145 | Chronic otitis media (HP:0000389) | 1.66801034 |
| 146 | Vertigo (HP:0002321) | 1.66690083 |
| 147 | Hemoptysis (HP:0002105) | 1.65360956 |
| 148 | Esophageal varix (HP:0002040) | 1.64961986 |
| 149 | Acne (HP:0001061) | 1.63371029 |
| 150 | Polygenic inheritance (HP:0010982) | 1.60457644 |
| 151 | Skin nodule (HP:0200036) | 1.59846978 |
| 152 | Supranuclear gaze palsy (HP:0000605) | 1.59337443 |
| 153 | Stroke (HP:0001297) | 1.58652601 |
| 154 | Joint swelling (HP:0001386) | 1.58281498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 5.40392282 |
| 2 | MAP3K14 | 4.04959896 |
| 3 | MAP3K3 | 3.36549467 |
| 4 | TGFBR2 | 3.28261764 |
| 5 | MST4 | 2.74947156 |
| 6 | TBK1 | 2.47877685 |
| 7 | MAP2K2 | 2.45821833 |
| 8 | DDR2 | 2.42033902 |
| 9 | TYK2 | 2.40948434 |
| 10 | IKBKB | 2.40876661 |
| 11 | NME2 | 2.27781700 |
| 12 | IKBKE | 2.18780057 |
| 13 | EPHA2 | 2.17405751 |
| 14 | IRAK3 | 2.15818788 |
| 15 | MAP3K2 | 2.10966431 |
| 16 | TAOK1 | 2.07425193 |
| 17 | GRK7 | 1.93875446 |
| 18 | PRPF4B | 1.75541153 |
| 19 | PIM2 | 1.74183144 |
| 20 | EPHB1 | 1.72001508 |
| 21 | MST1R | 1.69017798 |
| 22 | RIPK4 | 1.67241546 |
| 23 | CHUK | 1.65339683 |
| 24 | EPHA3 | 1.65303602 |
| 25 | ERN1 | 1.62216285 |
| 26 | STK10 | 1.61550082 |
| 27 | BMPR2 | 1.54484972 |
| 28 | IRAK4 | 1.47275845 |
| 29 | LATS2 | 1.45256654 |
| 30 | MAPKAPK5 | 1.37843876 |
| 31 | PBK | 1.34967271 |
| 32 | CDC42BPA | 1.34150967 |
| 33 | JAK1 | 1.33776767 |
| 34 | ABL2 | 1.32903813 |
| 35 | IRAK2 | 1.32844394 |
| 36 | VRK1 | 1.28814135 |
| 37 | MAPKAPK3 | 1.26213102 |
| 38 | TSSK6 | 1.15168761 |
| 39 | EIF2AK2 | 1.14936120 |
| 40 | CDK12 | 1.14921636 |
| 41 | MAP2K3 | 1.11030107 |
| 42 | FGR | 1.10864246 |
| 43 | MAP3K13 | 1.10493688 |
| 44 | TRPM7 | 1.09409339 |
| 45 | ERBB3 | 1.09100650 |
| 46 | BLK | 1.00927217 |
| 47 | RPS6KB2 | 0.94864230 |
| 48 | PDK2 | 0.94377537 |
| 49 | MAP3K11 | 0.90783707 |
| 50 | MAP3K1 | 0.90579190 |
| 51 | MAPKAPK2 | 0.89390062 |
| 52 | CAMK1D | 0.88914392 |
| 53 | MAPK7 | 0.88444963 |
| 54 | CDK3 | 0.87873388 |
| 55 | TIE1 | 0.86586768 |
| 56 | BMPR1B | 0.86079843 |
| 57 | MAP4K1 | 0.85841847 |
| 58 | FGFR4 | 0.83752867 |
| 59 | TXK | 0.82509395 |
| 60 | TAOK2 | 0.81901222 |
| 61 | RIPK1 | 0.80527248 |
| 62 | NLK | 0.77953923 |
| 63 | JAK3 | 0.76722009 |
| 64 | IRAK1 | 0.74198231 |
| 65 | JAK2 | 0.73516161 |
| 66 | NUAK1 | 0.73153021 |
| 67 | GSK3A | 0.72545866 |
| 68 | EPHB2 | 0.72039241 |
| 69 | ITK | 0.70866348 |
| 70 | FER | 0.70760751 |
| 71 | TEC | 0.70589106 |
| 72 | FGFR3 | 0.70238845 |
| 73 | HCK | 0.69432856 |
| 74 | SIK1 | 0.69112434 |
| 75 | SIK3 | 0.67896261 |
| 76 | CSF1R | 0.67180725 |
| 77 | PTK6 | 0.67020279 |
| 78 | MOS | 0.65935907 |
| 79 | RPS6KA1 | 0.62667498 |
| 80 | HIPK2 | 0.62396468 |
| 81 | CDK6 | 0.62373325 |
| 82 | RPS6KA4 | 0.61790681 |
| 83 | DYRK3 | 0.61392973 |
| 84 | DMPK | 0.60829909 |
| 85 | TGFBR1 | 0.60508940 |
| 86 | PIM1 | 0.60249828 |
| 87 | TAOK3 | 0.60185945 |
| 88 | ICK | 0.58506806 |
| 89 | ZAK | 0.57638905 |
| 90 | KIT | 0.54632403 |
| 91 | CSK | 0.53975160 |
| 92 | ABL1 | 0.53894354 |
| 93 | ADRBK2 | 0.52759645 |
| 94 | MATK | 0.51229093 |
| 95 | ZAP70 | 0.50448063 |
| 96 | NEK9 | 0.50162779 |
| 97 | AKT3 | 0.49773672 |
| 98 | NEK6 | 0.49768961 |
| 99 | LRRK2 | 0.49768793 |
| 100 | RPS6KA6 | 0.49153302 |
| 101 | PAK2 | 0.49109186 |
| 102 | DAPK3 | 0.49067373 |
| 103 | MAP2K1 | 0.48425725 |
| 104 | MTOR | 0.47680153 |
| 105 | PDGFRB | 0.46807755 |
| 106 | BRD4 | 0.46641809 |
| 107 | PDGFRA | 0.45895268 |
| 108 | GRK1 | 0.44429763 |
| 109 | LCK | 0.43508683 |
| 110 | MAPK4 | 0.43178775 |
| 111 | BMX | 0.43125494 |
| 112 | BTK | 0.42824141 |
| 113 | RPS6KC1 | 0.42580193 |
| 114 | RPS6KL1 | 0.42580193 |
| 115 | MARK2 | 0.42459670 |
| 116 | RPS6KA5 | 0.41187924 |
| 117 | CAMK1G | 0.40921624 |
| 118 | TYRO3 | 0.40119208 |
| 119 | DAPK2 | 0.39807247 |
| 120 | RPS6KA2 | 0.39565531 |
| 121 | DYRK1B | 0.38642920 |
| 122 | EIF2AK3 | 0.37517759 |
| 123 | MAP3K5 | 0.36216177 |
| 124 | STK24 | 0.35915747 |
| 125 | MARK3 | 0.35788771 |
| 126 | CLK1 | 0.35529147 |
| 127 | MAPK3 | 0.34353586 |
| 128 | CDK9 | 0.33895787 |
| 129 | WEE1 | 0.32782392 |
| 130 | PDPK1 | 0.31386107 |
| 131 | SGK3 | 0.30973430 |
| 132 | TRIB3 | 0.28425769 |
| 133 | LYN | 0.27116887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85808258 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57992571 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.44161197 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.31298063 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21834878 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.18838866 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.12467876 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.12082772 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.08923374 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.06337937 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.99696985 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.97173744 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.87054135 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.83024630 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.70801377 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.66555964 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60520084 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.57804857 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56633993 |
| 20 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.53599139 |
| 21 | Apoptosis_Homo sapiens_hsa04210 | 1.50601802 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.46670581 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.46416530 |
| 24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.45253539 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.44892413 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.40593829 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.38771174 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37054743 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37039639 |
| 30 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.36177354 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34885475 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33466974 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32751261 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.29673518 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26724151 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.25944854 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22279457 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19407815 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.18008880 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.10367363 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07297804 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07268223 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06976708 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 1.06103332 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05070348 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.04155205 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01592326 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00948543 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98332894 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.97868912 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94408523 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.94383000 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93310170 |
| 54 | Allograft rejection_Homo sapiens_hsa05330 | 0.92541570 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90425311 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90158464 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87852146 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.86029237 |
| 59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.85904372 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.84392007 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.83843111 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.81640245 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78895112 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72996751 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72355487 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.71677549 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69886920 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67928601 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67487159 |
| 70 | Prostate cancer_Homo sapiens_hsa05215 | 0.65482157 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65223494 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65107769 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64281385 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64195395 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63741499 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63137748 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60267910 |
| 78 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.58780455 |
| 79 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58450462 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57341649 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55593626 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52694646 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51472883 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51373479 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50410947 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49620601 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49569936 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49220724 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49122215 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.48383073 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48271186 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.47345544 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47135024 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46724861 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.46674419 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44632860 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43647676 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43012122 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.42685905 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42386700 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42148479 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41866559 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41810000 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40877521 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40045924 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.38997731 |
| 107 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38644887 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38280666 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37410859 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37187171 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36340168 |
| 112 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.36232143 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.34771188 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34723516 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34032280 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31978776 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29927151 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26633462 |
| 119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.24193399 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24186854 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22641463 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19759269 |

